MarketPeel
Pricing
…
GK

Gilbert H. Kliman

DOCS
DIRECTOR · DOXIMITY, INC. · CIK 0001293171
FILING MIX · LIFETIME52%/48%
BUYS
78
SELLS
71
TOTAL VALUE
$189.18M
COMPANIES
5
ACTIVE SINCE
May 2020
HOLDINGS NOW
3,892,042
AVG SELL PX
$33.47
TRADE KIND
SHOWING 149 / 149
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
22 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gilbert H. Kliman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d22+54.55%-5.32%+0.79%-6.11%-6.92%—
14d22+63.64%-7.02%+1.38%-8.20%-5.67%—
30d22+40.91%-4.08%+1.97%-6.05%-4.56%—
60d22+31.82%+0.45%+1.60%-1.14%+0.46%—
90d22+59.09%+2.96%+0.45%+2.51%-0.96%—
180d22(1 pending)+57.14%-7.08%+3.68%-10.76%-25.56%—
1y22(2 pending)+60.00%-14.89%+8.73%-23.62%-30.47%—
2y22(6 pending)+50.00%-17.34%+19.65%-37.70%-47.79%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DOCS · 449,960 shares · as of Aug 2, 2022
05,361,56210,723,12416,084,68621,446,2482022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 78 buys / 71 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GKOS
GLAUKOS CORP
PURCHASE
2,500$25.77$64.4K39,906Aug 19, 2026Aug 20, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
2,500——12,500Aug 19, 2026Aug 20, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
2,500$190.00$475.0K37,406Aug 19, 2026Aug 20, 2026 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,987——2,987May 28, 2026Jun 23, 2026 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,878——37,406May 28, 2026Jun 1, 2026 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,987——2,987May 28, 2026Jun 1, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$24.69$123.5K0May 14, 2026May 18, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$140.76$703.8K35,528May 14, 2026May 18, 2026 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
5,000$24.69$123.5K40,528May 14, 2026May 18, 2026 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
5,000$24.69$123.5K40,528May 11, 2026May 13, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$24.69$123.5K5,000May 11, 2026May 13, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$135.00$675.0K35,528May 11, 2026May 13, 2026 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
623——35,528Jan 2, 2026Jan 7, 2026 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$24.69$123.5K10,000Dec 9, 2025Dec 11, 2025 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$107.27$536.4K34,905Dec 9, 2025Dec 11, 2025 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
5,000$24.69$123.5K39,905Dec 9, 2025Dec 11, 2025 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,108——34,905May 29, 2025Jun 2, 2025 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,149——3,149May 29, 2025Jun 2, 2025 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
461——32,797Jan 2, 2025Jun 2, 2025 ↗View →
GKOS
GLAUKOS CORP
SALE
10,000——0Dec 20, 2024Dec 23, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE10b5-1
10b5-1 plan
10,000$150.28$1.50M32,336Dec 20, 2024Dec 23, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
10,000$32.00$320.0K42,336Dec 20, 2024Dec 23, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
2,000$144.01$288.0K32,336Dec 11, 2024Dec 13, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
2,000$32.00$64.0K34,336Dec 11, 2024Dec 13, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
2,000——10,000Dec 11, 2024Dec 13, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
3,000——12,000Sep 9, 2024Sep 11, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
1,000$130.00$130.0K32,336Sep 9, 2024Sep 11, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
3,000$32.00$96.0K35,336Sep 9, 2024Sep 11, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
2,000$131.00$262.0K33,336Sep 9, 2024Sep 11, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,246——1,246May 30, 2024Jun 3, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,716——32,336May 30, 2024Jun 3, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000——15,000May 30, 2024Jun 3, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
5,000$32.00$160.0K35,620May 30, 2024Jun 3, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$112.00$560.0K30,620May 30, 2024Jun 3, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000$88.25$441.3K30,620Mar 7, 2024Mar 8, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
5,000——20,000Mar 7, 2024Mar 8, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
5,000$32.00$160.0K35,620Mar 7, 2024Mar 8, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
3,145$86.01$270.5K5,202Mar 6, 2024Mar 8, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
5,202$84.93$441.8K0Mar 6, 2024Mar 8, 2024 ↗View →
GKOS
GLAUKOS CORP
SALE
8,000$92.00$736.0K8,347Feb 27, 2024Feb 29, 2024 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
895——30,620Jan 2, 2024Jan 4, 2024 ↗View →
STAA
STAAR SURGICAL CO
PURCHASEGRANT
Stock grant
366$32.99$12.1K10,457Dec 1, 2023Dec 4, 2023 ↗View →
STAA
STAAR SURGICAL CO
PURCHASEGRANT
Stock grant
435$40.18$17.5K10,091Sep 29, 2023Oct 3, 2023 ↗View →
GKOS
GLAUKOS CORP
SALE
10,000——0Aug 4, 2023Aug 8, 2023 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
10,000$7.28$72.8K39,725Aug 4, 2023Aug 8, 2023 ↗View →
GKOS
GLAUKOS CORP
SALE
10,000$74.56$745.6K29,725Aug 4, 2023Aug 8, 2023 ↗View →
STAA
STAAR SURGICAL CO
PURCHASE
3,417——9,656Jun 15, 2023Jun 16, 2023 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,230——29,725Jun 1, 2023Jun 5, 2023 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
1,572——26,495Jan 3, 2023Jan 4, 2023 ↗View →
GKOS
GLAUKOS CORP
SALE
2,382——24,923Aug 19, 2022Aug 19, 2022 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
2,382——16,347Aug 19, 2022Aug 19, 2022 ↗View →
GKOS
GLAUKOS CORP
SALE
3,362$53.01$178.2K0Aug 5, 2022Aug 8, 2022 ↗View →
GKOS
GLAUKOS CORP
SALE
83,955——0Aug 4, 2022Aug 8, 2022 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
83,955——83,955Aug 4, 2022Aug 8, 2022 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
19,045——27,305Aug 4, 2022Aug 8, 2022 ↗View →
GKOS
GLAUKOS CORP
SALE
333,917——0Aug 4, 2022Aug 8, 2022 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,714——449,960Aug 2, 2022Aug 5, 2022 ↗View →
DOCS
DOXIMITY, INC.
PURCHASEGRANT
Stock grant
4,714——454,674Jul 27, 2022Jul 29, 2022 ↗View →
STAA
STAAR SURGICAL CO
PURCHASE
355——3,340Jun 16, 2022Jun 17, 2022 ↗View →
STAA
STAAR SURGICAL CO
PURCHASE
2,899——6,239Jun 16, 2022Jun 17, 2022 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
4,364——8,260Jun 2, 2022Jun 6, 2022 ↗View →
GKOS
GLAUKOS CORP
SALE
980——3,896May 18, 2022May 18, 2022 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
980——13,965May 18, 2022May 18, 2022 ↗View →
DOCS
DOXIMITY, INC.
SALE
826$59.00$48.7K449,960Feb 25, 2022Feb 25, 2022 ↗View →
DOCS
DOXIMITY, INC.
SALE
29,174$56.09$1.64M450,786Feb 23, 2022Feb 25, 2022 ↗View →
BRZE
BRAZE, INC.
SALE
3,394,219——0Feb 8, 2022Feb 9, 2022 ↗View →
BRZE
BRAZE, INC.
PURCHASE
3,394,219——3,394,219Feb 8, 2022Feb 9, 2022 ↗View →
DOCS
DOXIMITY, INC.
SALE
8,912$63.00$561.5K485,940Dec 7, 2021Dec 8, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
5,980$62.00$370.8K479,960Dec 7, 2021Dec 8, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
2,000$65.82$131.6K494,852Dec 3, 2021Dec 6, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
1,101,094——1,101,094Dec 2, 2021Dec 6, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,300,000——8,556,998Dec 2, 2021Dec 6, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,300,000——0Dec 2, 2021Dec 6, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
1,101,094——0Dec 2, 2021Dec 6, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
4,300,000——4,300,000Dec 2, 2021Dec 6, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
249,778——496,852Dec 2, 2021Dec 6, 2021 ↗View →
BRZE
BRAZE, INC.
SALE
4,524,219——0Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
PURCHASE
4,524,219——4,524,219Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
SALE
1,130,000$61.42$69.40M0Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
PURCHASE
4,524,219——4,524,219Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
SALE
95,976——0Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
SALE
2,824,395——0Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
SALE
1,130,000——3,394,219Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
PURCHASE
1,130,000——1,130,000Nov 19, 2021Nov 23, 2021 ↗View →
BRZE
BRAZE, INC.
SALE
1,603,848——0Nov 19, 2021Nov 23, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
4,300,000——4,300,000Nov 12, 2021Nov 15, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,300,000——12,856,998Nov 12, 2021Nov 15, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
1,089,179——1,089,179Nov 12, 2021Nov 15, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
1,089,179——0Nov 12, 2021Nov 15, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,300,000——0Nov 12, 2021Nov 15, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
247,074——247,074Nov 12, 2021Nov 15, 2021 ↗View →
GKOS
GLAUKOS CORP
SALE
3,900——4,876Sep 8, 2021Sep 10, 2021 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
3,900——12,985Sep 8, 2021Sep 10, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
500,000——4,469,911Jul 13, 2021Jul 14, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
3,642——4,201Jul 13, 2021Jul 14, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
97,632——97,632Jul 13, 2021Jul 14, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
2,441——2,816Jul 13, 2021Jul 14, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
22,148——25,552Jul 13, 2021Jul 14, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
97,632——0Jul 13, 2021Jul 14, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
13,296,504——0Jun 28, 2021Jun 28, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
21,446,248——21,446,248Jun 28, 2021Jun 28, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,289,250——17,156,998Jun 28, 2021Jun 28, 2021 ↗View →
DOCS
DOXIMITY, INC.
PURCHASE
4,289,250——4,289,250Jun 28, 2021Jun 28, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
5,412,972——0Jun 28, 2021Jun 28, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
2,736,772——0Jun 28, 2021Jun 28, 2021 ↗View →
DOCS
DOXIMITY, INC.
SALE
4,289,250$24.57$105.39M0Jun 28, 2021Jun 28, 2021 ↗View →
STAA
STAAR SURGICAL CO
PURCHASE
850——850Jun 24, 2021Jun 25, 2021 ↗View →
STAA
STAAR SURGICAL CO
PURCHASEGRANT
Stock grant
404——2,985Jun 24, 2021Jun 25, 2021 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
2,382——8,776Jun 3, 2021Jun 7, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
125——375May 10, 2021May 12, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,135——3,404May 10, 2021May 12, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
5,000——5,000May 10, 2021May 12, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
186——559May 10, 2021May 12, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
500,000——4,969,911May 10, 2021May 12, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
5,000——0May 10, 2021May 12, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
373——373Mar 24, 2021Mar 25, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
10,000——0Mar 24, 2021Mar 25, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,000,000——5,469,911Mar 24, 2021Mar 25, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
10,000——10,000Mar 24, 2021Mar 25, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
2,269——2,269Mar 24, 2021Mar 25, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
250——250Mar 24, 2021Mar 25, 2021 ↗View →
GKOS
GLAUKOS CORP
SALE
300,000——333,917Mar 3, 2021Mar 5, 2021 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
3,000——3,000Mar 3, 2021Mar 5, 2021 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
680——6,394Mar 3, 2021Mar 5, 2021 ↗View →
GKOS
GLAUKOS CORP
SALE
3,000——0Mar 3, 2021Mar 5, 2021 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
980——5,714Jan 4, 2021Jan 6, 2021 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,040,654——6,204,153Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,620,101——1,675,101Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,040,654——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
3,488,398——5,163,499Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,620,101——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
265,203——6,469,356Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
3,488,398——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
265,203——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
265,203——0Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
3,488,398——0Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
265,203——6,469,911Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,620,101——0Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
3,488,398——5,164,054Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,040,654——6,204,708Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,040,654——0Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,620,101——1,675,656Sep 29, 2020Oct 2, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
55,000$18.00$990.0K55,000Sep 25, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
55,555$18.00$1000.0K55,555Sep 25, 2020Oct 2, 2020 ↗View →
STAA
STAAR SURGICAL CO
PURCHASEGRANT
Stock grant
2,117——2,581Jul 30, 2020Aug 4, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASEGRANT
Stock grant
3,900——4,734Jun 3, 2020Jun 5, 2020 ↗View →
STAA
STAAR SURGICAL CO
PURCHASEGRANT
Stock grant
464——464Jun 1, 2020Jun 3, 2020 ↗View →
GKOS
GLAUKOS CORP
PURCHASE
834——834May 8, 2020May 12, 2020 ↗View →
GKOS
GLAUKOS CORP
SALE
367,000——633,917May 8, 2020May 12, 2020 ↗View →
Other insiders · DOCS
Loading peer insiders…
About this filer
CIK 0001293171
ROLE
Director
PRIMARY
DOCS
COMPANIES
5
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001293171DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback